Takeda Pharmaceutical (TAK) Prepaid Assets (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Prepaid Assets of $1.2 billion for Q2 2026, up 14.2% on a QoQ basis from $1.0 billion in Q1 2026, and down 1.36% year-over-year from $1.2 billion in Q2 2025.
Analysis
Takeda Pharmaceutical (TAK) Prepaid Assets (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical has reported Prepaid Assets for 10 years, with the latest figure at $1.2 billion in Q2 2026.
- On a quarterly basis, Prepaid Assets fell 1.36% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $1.2 billion, a 1.36% decrease from a year earlier, with the FY2026 full-year figure at $1.0 billion, down 1.02% from the prior year.
- Prepaid Assets was $1.2 billion for Q2 2026 at Takeda Pharmaceutical, up from $1.0 billion in the prior quarter.
- The five-year high for Prepaid Assets was $1.3 billion in Q2 2023, with the low at $1.0 billion in Q1 2026.
- Average Prepaid Assets over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets gained 10.74% in 2023, then declined 12.42% in 2024.
- Over 5 years, Prepaid Assets stood at $1.1 billion in 2022, then advanced by 10.74% to $1.2 billion in 2023, then retreated by 2.84% to $1.2 billion in 2024, then fell by 3.13% to $1.1 billion in 2025, then increased by 3.69% to $1.2 billion in 2026.
- The last three Prepaid Assets figures came in at $1.2 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn |
| 10 | Takeda Pharmaceutical | 2.62 Bn | -3.18 Bn | 5.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.13 Bn |
| Jun 30, 2025 | 1.20 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.08 Bn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 1.23 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.10 Bn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.22 Bn |
| Sep 30, 2021 | 1.20 Bn |